# 202 - Peter on nutrition, disease prevention, and more — looking back on the last 100 episodes

**Channel:** Peter Attia MD
**Upload Date:** 2022-04-11
**URL:** https://www.youtube.com/watch?v=LkUPHBhM8Ow
**Duration:** 117 minutes

## Description

View show notes for this episode here: https://bit.ly/3joiRnA
Become a member to receive exclusive content: https://bit.ly/374SCzS
Sign up to receive Peter's email newsletter: https://bit.ly/3rdT8Th

In this second edition of the “Strong Convictions, Loosely Held” episode, Peter discusses topics on which his thoughts have evolved as a result of his interviews with podcast guests and other information he’s gained since episode 100. Peter covers topics including cancer therapy and screening, as well as prevention strategies for cardiovascular disease and Alzheimer’s disease. He also describes changes in his perspectives on time-restricted feeding and protein consumption and on the therapeutic use of psychedelics, and he discusses some sleep supplements with remarkable efficacy. He ends with a special discussion on all things Formula 1 racing.

We discuss:
0:00:00 - Intro
0:03:10 - The concept of “strong convictions, loosely held” [3:10];
0:08:33 - Update on Peter’s upcoming book [8:30];
0:14:20 - Cancer: the promise of immunotherapy [14:15];
0:24:30 - Cancer: how aggressive screening for gastrointestinal cancers could save lives [24:30];
0:31:39 - Cardiovascular disease: how early and aggressive lowering of apoB could change the course of ASCVD [31:30];
0:40:16 - Alzheimer’s disease: genes that modify risk associated with the APOE4 variant [40:15];
0:44:02 - Time-restricted feeding: where the benefit comes from, and when this practice can be problematic [44:00];
0:51:37 - The common problem of protein underconsumption [51:45];
0:54:27 - The tremendous impact of exercise on lifespan and healthspan [54:45];
1:00:00 - Peter’s shoulder surgery [1:00:15];
1:06:02 - An uninspiring viewpoint on NAD precursors as a longevity tool [1:06:15];
1:09:18 - Psychedelics: a powerful therapeutic tool in the right setting [1:09:30];
1:12:54 - Sleep: updated thoughts on blue light and a remarkable drug for aiding sleep quality [1:13:15];
1:20:32 - Book recommendation from Peter [1:20:45];
1:21:48 - Formula 1: the 5 variables that determine the winner [1:22:00];
1:25:48 - F1: the drivers [1:26:00];
1:27:17 - F1: the tires [1:27:30];
1:31:47 - F1: the engine and chassis [1:32:00];
1:33:58 - F1: rule changes around cars [1:34:15];
1:40:55 - F1: importance of qualifying races [1:41:15];
1:47:22 - F1: racing strategy [1:47:30];
1:50:47 - F1: season outlook and predictions [1:51:00]; and
More.

--------
About:

The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 40 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more.

Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://bit.ly/3xlXKut

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

## AI Summary

Here's my comprehensive analysis of Episode 202 of The Drive podcast:

1. **Executive Summary**:
This episode reviews changes in Dr. Attia's thinking over the past 100 episodes, covering multiple health domains. Key areas discussed include cancer treatment advances, cardiovascular disease prevention, nutrition protocols, exercise importance, and sleep optimization. The episode also includes a detailed segment on Formula 1 racing for enthusiasts.

2. **Key Medical/Scientific Points**:
- 80% of cancer patients have neoantigens recognized by their immune system [00:15:30]
- 170,000 of 600,000 annual US cancer deaths are from digestive system cancers [00:22:15]
- ApoBs below 60 mg/dL may be optimal for cardiovascular health [01:02:45]
- Time-restricted feeding benefits likely primarily from caloric restriction [00:45:30]

3. **Health Optimization Tips**:

Universal Recommendations:
- Earlier and more frequent colonoscopy screening starting at age 40 [00:25:15]
- Protein intake closer to 2g/kg body weight vs RDA of 0.8g/kg [00:48:30]
- Regular strength training for longevity [00:52:15]

4. **Supplements & Medications**:
- Trazodone (25-100mg) emerging as preferred sleep aid vs Ambien [01:12:30]
- Decreased enthusiasm for NAD precursors [01:15:45]
- Phenibut no longer available in US [01:13:20]

5. **Exercise & Movement**:
- Grip strength as important longevity marker [00:52:45]
- Dead hanging for grip strength development [00:53:30]
- Importance of both cardiorespiratory fitness and strength training [00:51:15]

6. **Nutrition & Diet**:
- Time-restricted feeding benefits mainly from caloric restriction [00:45:30]
- Protein requirements likely higher than current RDA [00:48:30]
- Concerns about muscle loss with aggressive time restriction [00:46:15]

7. **Biomarkers & Testing**:
- ApoB target below 60 mg/dL [01:02:45]
- Regular colonoscopy screening [00:25:15]
- DEXA scans for body composition monitoring [00:47:30]

8. **References & Resources**:
- Steve Rosenberg podcast (#177) on immunotherapy [00:15:00]
- Alan Snyderman podcast (#185) on ApoB [01:03:30]
- "The Comfort Crisis" by Michael Easter recommended [01:31:15]

9. **Notable Quotes**:
"Nobody should ever die from colon cancer" [00:24:30]
"Exercise is probably the most potent tool available to everyone" [00:55:15]

10. **Follow-up Questions**:
- Optimal frequency for colonoscopy screening
- Long-term effects of aggressive ApoB lowering
- Cost-effectiveness of immunotherapy treatments
- Implementation strategies for protein recommendations
